CVHL75PP1

Durapore^® 0.45 µm, Cartridge

pore size 0.45 μm, cartridge nominal length 5 in. (12.5 cm), Code 7 (2-226; O-rings w/locking-tabs)

• Synonim(y): Durapore Cartridge Filter without prefilter 5 in. 0.45 μm Code 7
• Kod UNSPSC: 23151806
• eCl@ss: 32031690

Właściwości

• Materiały: PVDF ; polypropylene ; polypropylene support; silicone seal
• Poziom jakości: 400
• zgodność regionalna: meets EU framework regulation [1935/2004/EC] (all component materials; regarding materials and articles intended to contact food); meets FDA Indirect Food Additive requirements cited in 21 CFR 177-182 (all component materials)
• sterylność: non-sterile
• Kompatybilność ze sterylizacją: autoclavable compatible; steam-in-place compatible
• linia produktu: Durapore^®
• Właściwości: hydrophilic
• producent / nazwa handlowa: Durapore^®
• Parametry: 0.35 bar max. differential pressure (5 psid) at 135 °C (Forward); 0.35 bar max. inlet pressure (5 psi) at 135 °C (Forward); 1.7 bar max. differential pressure (25 psid) at 80 °C (Forward); 1.7 bar max. inlet pressure (25 psi) at 80 °C (Forward); 3.5 bar max. differential pressure (50 psid) at 25 °C (Reverse); 3.5 bar max. inlet pressure (50 psi) at 25 °C (Reverse); 5.5 bar max. differential pressure (80 psid) at 25 °C (Forward); 5.5 bar max. inlet pressure (80 psi) at 25 °C (Forward)
• metody: bioburden reduction: suitable
• Długość: 5 in.
• Szerokość: 2.7 in.
• długość nominalna kartridża: 5 in. (12.5 cm)
• Średnica: 7.1 cm (2.8 in.)
• powierzchnia filtracyjna: 0.35 m²
• zanieczyszczenia: ≤0.5 EU/mL bacterial endotoxins (LAL test, Aqueous extraction); <0.5 EU/mL USP bacterial endotoxins (LAL test, sample aqueous extraction)
• substancje ekstrahujące się grawimetrycznie: ≤10 mg/cartridge
• Matryca: Durapore^®
• wielkość porów: 0.45 μm pore size
• moc wejściowa: sample type liquid
• punkt pęcherzykowania: ≥1930 mbar (28 psig), air with water at 23 °C
• kod wkładu: Code 7 (2-226; O-rings w/locking-tabs)

Opis

Opis ogólny

Device Configuration: Cartridge

Opakowanie

Double Easy-Open bag

Inne uwagi

These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.

Directions for Use

• Organism Retention: Microorganism
• Mode of Action: Filtration (size exclusion)
• Application: BioProcessing
• Intended Use: Reduction or removal of microorganism/bioburden
• Instructions for Use: Please refer Wetting Instructions for Filter Units with Durapore^® Membrane user guide
• Storage Statement: Store in dry location
• Disposal Statement: Dispose of in accordance with applicable federal, state and local regulations.

Uwaga dotycząca przygotowania

Sterilization Method
30 SIP cycles of 30 min @ 135 °C; 30 autoclave cycles of 60 min @ 126 °C

This product was manufactured with a Durapore^® membrane which meets the criteria for a "non-fiber releasing" filter as defined in 21 CFR 210.3 (b) (6).

Komentarz do analizy

Gravimetric Extractables: after 24 hours in water at controlled room temperature

Informacje prawne

Durapore is a registered trademark of Merck KGaA, Darmstadt, Germany

Ta strona może zawierać tekst przetłumaczony maszynowo.